Th9 and Th22 immune response in young patients with type 1 diabetes
- PMID: 26659093
- DOI: 10.1007/s12026-015-8765-7
Th9 and Th22 immune response in young patients with type 1 diabetes
Abstract
Th17, Th22 and Th9 are recently discovered effector populations that may contribute to the pathogenesis of autoimmune and inflammatory diseases. The presented study aimed to investigate the link between Th22 and Th9 subsets in type 1 diabetes, as this disease involves different subsets of CD4+ T lymphocytes. The study groups consisted of 23 patients with type 1 diabetes and 11 healthy individuals. All subjects had CD4+IL-22 Th22 and CD4+IL-9 Th9 lymphocytes investigated by flow cytometry. In addition, the plasma concentrations of IL-22 as well as IL-9 were analyzed. Our study demonstrated that Th9 and Th22 cell counts as well as their plasma cytokines were upregulated in patients with type 1 and correlated with HbA1c and CRP values. Taking these all into account, one can conclude that Th22 and Th9 lymphocyte activities may contribute to chronic, low-level inflammation that is considered an integral part of type 1 diabetes.
Keywords: IL-22; IL-9; Th22; Th9; Type 1 diabetes.
Similar articles
-
Circulating Th1, Th2, Th9, Th17, Th22, and Treg Levels in Aortic Dissection Patients.Mediators Inflamm. 2018 Sep 6;2018:5697149. doi: 10.1155/2018/5697149. eCollection 2018. Mediators Inflamm. 2018. PMID: 30258282 Free PMC article.
-
Severe atopic dermatitis is characterized by selective expansion of circulating TH2/TC2 and TH22/TC22, but not TH17/TC17, cells within the skin-homing T-cell population.J Allergy Clin Immunol. 2015 Jul;136(1):104-115.e7. doi: 10.1016/j.jaci.2015.01.020. Epub 2015 Mar 3. J Allergy Clin Immunol. 2015. PMID: 25748064
-
Existence of Th22 in children and evaluation of IL-22 + CD4 + T, Th17, and other T cell effector subsets from healthy children compared to adults.BMC Immunol. 2016 Jun 23;17(1):20. doi: 10.1186/s12865-016-0158-8. BMC Immunol. 2016. PMID: 27338754 Free PMC article.
-
Effector and regulatory T cell subsets in diabetes-associated inflammation. Is there a connection with ST2/IL-33 axis? Perspective.Autoimmunity. 2014 Sep;47(6):361-71. doi: 10.3109/08916934.2014.886198. Epub 2014 Feb 19. Autoimmunity. 2014. PMID: 24547981 Review.
-
T Helper (Th) Cell Profiles in Pregnancy and Recurrent Pregnancy Losses: Th1/Th2/Th9/Th17/Th22/Tfh Cells.Front Immunol. 2020 Aug 18;11:2025. doi: 10.3389/fimmu.2020.02025. eCollection 2020. Front Immunol. 2020. PMID: 32973809 Free PMC article. Review.
Cited by
-
IL-10 Modulates Th17 Pathogenicity during Autoimmune Diseases.J Clin Cell Immunol. 2016 Apr;7(2):400. doi: 10.4172/2155-9899.1000400. Epub 2016 Mar 22. J Clin Cell Immunol. 2016. PMID: 27308096 Free PMC article.
-
Increased interleukin-9 and Th9 cells in patients with refractory Graves' disease and interleukin-9 polymorphisms are associated with autoimmune thyroid diseases.Front Immunol. 2024 Mar 28;15:1341749. doi: 10.3389/fimmu.2024.1341749. eCollection 2024. Front Immunol. 2024. PMID: 38605942 Free PMC article.
-
Sex-dependent effects of bisphenol A on type 1 diabetes development in non-obese diabetic (NOD) mice.Arch Toxicol. 2019 Apr;93(4):997-1008. doi: 10.1007/s00204-018-2379-5. Epub 2019 Jan 2. Arch Toxicol. 2019. PMID: 30600366 Free PMC article.
-
miRNA Regulation of T Cells in Islet Autoimmunity and Type 1 Diabetes.Curr Diab Rep. 2020 Jul 28;20(9):41. doi: 10.1007/s11892-020-01325-9. Curr Diab Rep. 2020. PMID: 32725277 Free PMC article. Review.
-
Expression and role of interleukin-9 in Vogt-Koyanagi-Harada disease.Mol Vis. 2017 Jul 31;23:538-547. eCollection 2017. Mol Vis. 2017. PMID: 28761327 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous